Our analysis of publicly available gene expression profiles revealed that high levels of CREB1 are associated with better prognosis in ERα-positive breast cancers, i.e., that they must have a protective effect in patients as well, and not just in cells. This evidence concerns the gene CREB1 and breast cancer.